O Kavanagh, MK Estes, A Reeck… - Clinical and Vaccine …, 2011 - Am Soc Microbiol Page 1. Serological Responses to Experimental NorwalkVirus Infection Measured Using a 1 Quantitative Duplex Time-Resolved Fluorescence Immunoassay 2 ... measure Norwalkvirus (NV)-specific IgA and IgG antibodies simultaneously. The duplex 3 ... Related articles - All 3 versions
LS Velasquez, S Shira, AN Berta, J Kilbourne… - Vaccine, 2011 - ncbi.nlm.nih.gov The development of a vaccine to prevent norovirus infections has been focused on immunization at a mucosal surface, but has been limited by the low immunogenicity of self-assembling Norwalk virus-like particles (NV VLPs) delivered enterically or at nasal surfaces. Nasal ...
D Dou, KC Tiew, G He, SR Mandadapu… - Bioorganic & Medicinal …, 2011 - Elsevier Note to users: The section "Articles in Press" contains peer reviewed accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated ...
KC Tiew, G He, S Aravapalli… - Bioorganic & Medicinal …, 2011 - Elsevier The first series of peptidyl aldehyde inhibitors that incorporate in their structure a glutamine surrogate has been designed and synthesized based on the known substrate specificity of Norwalk virus 3C protease. The inhibitory activity of the compounds with the protease and ...
D Takahashi, Y Kim, KO Chang… - Biophysical …, 2011 - adsabs.harvard.edu Title: Solution Structure Determination of NorwalkVirus 3C-Like Cysteine Protease. Authors: Takahashi, Daisuke; Kim, Yunjeong; Chang, Kyeong-Ok; Anbanandam, Asokan; Prakash, Om. Publication: Biophysical Journal, vol. 100, issue 3, pp. 605a-606a. ... All 2 versions